Pneumonia (Pediatric) Clinical Trials

A listing of Pneumonia (Pediatric) medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 87 clinical trials
None
Exhaled Breath Analysis to Predict Risk of Symptomatic Pneumonitis

This is a prospective pilot study investigating exhaled breath condensate analyses to quantify the variability over time of various biomarkers associated with symptomatic pneumonitis.

cancer
lung cancer
  • 0 views
  • 07 Oct, 2021
  • 1 location
None
ZAVI APD ELF Protocol v2.2

CAZ/AVI is a new antibiotic drug that is meant to be used for various indications including cIAI and nosocomial pneumonia. To date, limited data exists on PK of CAZ/AVI in patients undergoing peritoneal dialysis as well as on penetration of CAZ/AVI in ELF of critically ill patients. The present study …

critical illness
antibiotics
dialysis
nosocomial pneumonia
antibiotic therapy
  • 2 views
  • 16 Sep, 2021
  • 1 location
None
Validation of Aspiration Markers in Intubated Patients

The goal of this interventional study is to test Quinine as marker of aspiration (endotracheal tube [ETT] cuff leakage) in mechanically ventilated, critically ill patients.

critical illness
  • 9 views
  • 26 Jan, 2021
  • 1 location
None
Blue Light Therapy in Reducing Inflammation During Sepsis

Our data suggest that modulating the characteristics of light carries the potential to modify the host response to injury and critical illness and thus, improve outcome. The ability to modify the host response to the stress of major operations and sepsis carries immense potential to improve patient care. This study …

critical illness
sepsis
abscess
white blood cell count
a 12
  • 119 views
  • 08 Sep, 2021
  • 1 location
None
Predictive Factors of Good Pulmonary Penetration of Antibiotics : AntiBiotics Dosage in Broncho-Alveolar Lavage

Respiratory infections are common and sometimes very severe. An insufficient dosage of the antibiotic could lead to a treatment failure A correct plasmatic antibiotic concentration is not a guarantee of a clinical success as it could not be a reflect of pulmonary concentration. The aim of this study is to …

amoxicillin
antibiotics
ceftazidime
cephalosporins
antibiotic therapy
  • 0 views
  • 26 Jan, 2021
  • 1 location
None
Closed-Loop Oxygen to Verify That Healthcare Workers Interventions Decrease During SARS-CoV-2 Pneumonia (COVID-19)

There is a high risk of transmission of COVID-19 to healthcare workers. In a recent cohort, 29% of the patients hospitalized were healthcare workers. Among the WHO's primary strategic objectives for the response to COVID-19, the first was to limit human-to-human transmission, including reducing secondary infections among close contacts and …

community acquired pneumonia
respiratory failure
FIO2
covid-19
SARS
  • 0 views
  • 24 Jan, 2021
  • 1 location
None
Low-Dose Radiotherapy For Patients With SARS-COV-2 (COVID-19) Pneumonia

Low doses of radiation in the form of chest x-rays has been in the past to treat people with pneumonia. This treatment was thought to reduce inflammation and was found to be effective without side effects. However, it was an expensive treatment and was eventually replaced with less expensive treatment …

shortness of breath
cancer
fever
x-rays
cough
  • 15 views
  • 21 Mar, 2021
  • 8 locations
None
Inflammatory Signal Inhibitors for COVID-19 (MATIS)

The Multi-arm trial of Inflammatory Signal Inhibitors for COVID-19 (MATIS) study is a two-stage, open-label, randomised controlled trial assessing the efficacy of ruxolitinib (RUX) and fostamatinib (FOS) individually, compared to standard of care in the treatment of COVID-19 pneumonia. The primary outcome is the proportion of hospitalised patients progressing from …

pneumonia
covid-19
  • 7 views
  • 11 Sep, 2021
  • 1 location
None
Ultraprotective Ventilation Without Extracorporeal Circulation During COVID 19 Pneumonia

Mortality of COVID-19 pneumonia with acute respiratory distress syndrome (ARDS) is extremely high in preliminary reports amounting to 50-60%. Duration of mechanical ventilation in these patients appears to exceed standard duration of mechanical ventilation in non-COVID-19 ARDS patients, suggesting that COVID-19 patients may be particularly at risk for ventilator-induced lung …

  • 0 views
  • 25 Feb, 2021
  • 11 locations
None
Treatment of ARDS With Instilled T3

It is hypothesized that instillation of (T3) into the airspace will increase alveolar fluid clearance in patients with ARDS, resulting in reduced extravascular lung water (EVLW).

pao2
x-rays
FIO2
chest x-ray
bilateral pulmonary infiltrates
  • 17 views
  • 03 Oct, 2021
  • 5 locations